Pacific Coast Society of Orthodontists Bulletin Fall 2017 - 28

Let's Talk About That

increase tooth mobility? If a medication adversely
affects orthodontics, consult with the patient's
physician to evaluate possible alternate medications, discontinuation of medication, or discontinuation of orthodontic treatment. Facts and
Comparisons contains every medication approved
by the FDA. It costs about $300 and is updated
every one to two years. Free online sources
include Drugs.com and A-Z Drug Facts (publishers of Facts & Comparisons).
PT: Jim, thank you so much for taking the time
to provide this important information to our
readers. I will be using this article as a reference
when faced with any of the situations you have
addressed. Your expertise is much appreciated.

References
1. Vivaldi-Rodrigues G, Demito CF, Bowman SJ, Ramos
AL. The effectiveness of a fluoride varnish in preventing
the development of white spot lesions. World J Orthod
2006;7:138-144.
2. Farhadian N, Miresmaeili A, Eslami B, Mehrabi S.
Effect of fluoride varnish on enamel demineralization
around brackets: an in-vivo study. Am J Orthod Dentofacial Orthop 2008;133(4 Supp):S95-98.
3. He T, Li X, Dong Y, et al. Comparative assessment of
fluoride varnish and fluoride film for remineralization
of postorthodontic white spot lesions in adolescents
and adults over a 6-month period: A single-center,
randomized controlled clinical trial. Am J Orthod Dentofacial Orthop 2016;149:810-819.

4 Wilson W, Taubert KA, Gewitz M, et al. Prevention of
infective endocarditis: guidelines from the American
Heart Association: a guideline from the American
Heart Association Rheumatic Fever, Endocarditis and
Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical
Cardiology, Council on Cardiovascular Surgery and
Anesthesia, and the Quality of Care and Outcomes
Research Interdisciplinary Working Group. J Am Dent
Assoc 2008;139:3S-24S.
5. Ong CK, Lirk P, Tan CH, Seymour RA. An evidencebased update on nonsteroidal anti-inflammatory
drugs. Clin Med Res 2007;5:19-34.
6. Moore RA, Straube S, Paine J, Derry S, McQuay HJ.
Minimum efficacy criteria for comparisons between
treatments using individual patient meta-analysis of
acute pain trials: examples of etoricoxib, paracetamol,
ibuprofen, and ibuprofen/paracetamol combinations
after third molar extraction. Pain 2011;152:982-989.
7. Lotwala RB, Greenlee GM, Ott SM, Hall SH, Huang GJ.
Bisphosphonates as a risk factor for adverse orthodontic outcomes: a retrospective cohort study. Am J Orthod
Dentofacial Orthop 2012:142:625-634.
8. Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F.
Occurrence and risk indicators of medication-related
osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol
2015;42:922-932.
9. Fleisher KE, Welch G, Kottal S, Craig RG, Saxena D,
Glickman RS. Predicting risk for bisphosphonate-related
osteonecrosis of the jaws: CTX versus radiographic
markers. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2010;110:509-516.

PCSO Bulletin  Fall 2017

http://Drugs.com

Table of Contents for the Digital Edition of Pacific Coast Society of Orthodontists Bulletin Fall 2017